Statistics for Burning Rock Biotech Ltd (id:6636 BNR)

Valuation metrics

Market cap

57.45M

Enterprise value

20.69M

Trailing P/E (ttm)

-0.10

Forward P/E

-9.66

PEG ratio

-9.66

Price/Sales (ttm)

0.11

Price/Book (mrq)

0.08

Enterprise Value/Revenue

0.29

Enterprise Value/EBITDA

-0.34

Overview

Shares outstanding

8.53M

Float

55.77M

Shares short

120.30K

% Held by insiders

0.00%

% Held by institutions

0.61%

Average volume (10 days)

19.59K

Average volume (90 days)

Price summary

52-Week low

0.57

52-Week high

8.99

52-Week change

86.64%

Beta

0.14

50-Day moving average

3.40

200-Day moving average

6.18

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

May 15, 2024

Financials

Fiscal year

Fiscal year ends

December 31, 2023

Most recent quarter (mrq)

June 30, 2024

Profitability

Profit margin

-111.18%

Operating margin

-82.06%

Operational effectiveness

Return on assets

-30.91%

Return on equity

-68.89%

Income statement

Revenue (ttm)

49.75

Revenue per share (ttm)

49.75

Quarterly revenue growth (yoy)

Gross profit (ttm)

363.23M

EBITDA

-61,466,549.00

Net income to common (ttm)

-78,221,444.00

Diluted EPS (ttm)

-7.64

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

73.50M

Total cash per share (mrq)

5.19

Total debt (mrq)

14.89M

Total Debt/Equity (mrq)

15.92

Current ratio (mrq)

310.50%

Book value per share (mrq)

66.07

Cash flow

Cash flow statement

-19,939,821.00

Levered free cash flow (LFCF)

1.06M